Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$1.20 USD
+0.09 (8.13%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $1.19 -0.01 (-0.85%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.51 | -11.76% |
Earnings Summary
For their last quarter, Bolt Biotherapeutics (BOLT) reported earnings of -$0.47 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for BOLT's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.51 per share, reflecting a year-over-year decrease of 13.33%.
Earnings History
Price & Consensus
Zacks News for BOLT
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Surpass Estimates
BOLT: What are Zacks experts saying now?
Zacks Private Portfolio Services